These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28482791)

  • 1. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies.
    Patel P; Patel VK; Singh A; Jawaid T; Kamal M; Rajak H
    Curr Comput Aided Drug Des; 2019; 15(2):145-166. PubMed ID: 29732991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches.
    Adhikari N; Amin SA; Trivedi P; Jha T; Ghosh B
    Eur J Med Chem; 2018 Sep; 157():1127-1142. PubMed ID: 30179749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.
    Juvale DC; Kulkarni VV; Deokar HS; Wagh NK; Padhye SB; Kulkarni VM
    Org Biomol Chem; 2006 Aug; 4(15):2858-68. PubMed ID: 16855733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors.
    Sirous H; Campiani G; Brogi S; Calderone V; Chemi G
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32331470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of quinazolinyl-containing benzamides derivatives as novel HDAC1 inhibitors with in vitro and in vivo antitumor activities.
    Zhang Z; Zhang Q; Zhang H; Jiao M; Guo Z; Peng X; Fu L; Li J
    Bioorg Chem; 2021 Dec; 117():105407. PubMed ID: 34653945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
    Abdizadeh T; Kalani MR; Abnous K; Tayarani-Najaran Z; Khashyarmanesh BZ; Abdizadeh R; Ghodsi R; Hadizadeh F
    Eur J Med Chem; 2017 May; 132():42-62. PubMed ID: 28340413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
    Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T
    Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
    Pourbasheer E; Aalizadeh R
    SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR of aminophenyl benzamide derivatives as histone deacetylase inhibitors.
    Mahipal ; Tanwar OP; Karthikeyan C; Moorthy NS; Trivedi P
    Med Chem; 2010 Sep; 6(5):277-85. PubMed ID: 20977417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.